Hospital Egas Moniz, Lisbon, Portugal.
J Refract Surg. 2012 Aug;28(8):551-5. doi: 10.3928/1081597X-20120703-03. Epub 2012 Jul 13.
To compare the visual outcomes and wavefront analyses of patients who underwent cataract surgery with the implantation of a Tecnis toric intraocular lens (IOL) (Abbott Medical Optics) with those patients who received an Acrysof IQ toric IOL (Alcon Laboratories Inc).
The study included 40 eyes from 26 patients with regular corneal astigmatism between 1.00 and 3.00 diopters (D) who were undergoing phacoemulsification with implantation of a toric IOL. Patients were randomized into two groups (20 eyes in each group): one group received the Tecnis toric IOL (Tecnis group) and one group received the Acrysof IQ toric IOL (Acrysof group). Over a 2-month follow-up period, the main outcome measures were uncorrected (UDVA) and corrected distance visual acuity (CDVA), spherical equivalent refraction, residual astigmatism, rotational stability of the IOL, and higher order aberrations, measured with a dynamic retinoscopy aberrometer.
At 2-month follow-up, UDVA, CDVA, spherical equivalent refraction, and residual astigmatism showed no statistically significant between-group differences (P=.834, P=.178, P=.447, and P=.166, respectively). No eye had IOL rotation >10°. The toric IOL axis misalignment was similar in both groups (3.15°±2.62° in the Tecnis group and 3.25°±2.04° in the Acrysof group, P=.265). No statistically significant between-group differences were noted for all ocular aberrometry values, except for spherical aberration, which was higher in the Acrysof group (P=.029).
Both studied IOLs promoted good postoperative UDVA, CDVA, and refractive results. Rotational stability was excellent for both IOLs. Postoperative spherical aberration was higher for the Acrysof toric IOL; however, this difference did not seem to affect overall visual quality.
比较行白内障超声乳化摘除联合 TORIC 人工晶状体(IOL)植入术患者的视力结果和波前像差,其中 IOL 分别为 Tecnis Toric IOL( Abbott Medical Optics)和 Acrysof IQ Toric IOL(Alcon Laboratories Inc)。
本研究纳入 26 例患者共 40 只眼,这些患者均有规则性角膜散光 1.00 至 3.00 屈光度(D),行白内障超声乳化摘除联合 TORIC IOL 植入术。患者随机分为两组(每组 20 只眼):Tecnis Toric IOL 组(Tecnis 组)和 Acrysof IQ Toric IOL 组(Acrysof 组)。术后 2 个月随访时,主要观察指标包括未矫正远视力(UDVA)、矫正远视力(CDVA)、等效球镜度数、残余散光、IOL 旋转稳定性和高阶像差,使用动态视网膜像差仪进行测量。
术后 2 个月随访时,两组间 UDVA、CDVA、等效球镜度数和残余散光差异均无统计学意义(P=.834、P=.178、P=.447 和 P=.166)。无一例 IOL 旋转超过 10°。两组的 TORIC IOL 轴位均无明显偏差(Tecnis 组为 3.15°±2.62°,Acrysof 组为 3.25°±2.04°,P=.265)。两组间除球差外,其他各眼像差值差异均无统计学意义,而 Acrysof 组的球差值更高(P=.029)。
两种研究 IOL 均能获得良好的术后 UDVA、CDVA 和屈光结果。两种 IOL 的旋转稳定性均良好。术后 Acrysof Toric IOL 的球差更高,但这种差异似乎并未影响整体视觉质量。